부산대학교 도서관

Mohile, Supriya G ; Mohamed, Mostafa R ; Xu, Huiwen ; Culakova, Eva ; Loh, Kah Poh ; Magnuson, Allison ; Flannery, Marie A ; Obrecht, Spencer ; Gilmore, Nikesha ; Ramsdale, Erika ; Dunne, Richard F ; Wildes, Tanya ; Plumb, Sandy ; Patil, Amita ; Wells, Megan ; Lowenstein, Lisa ; Janelsins, Michelle ; Mustian, Karen ; Hopkins, Judith O ; Berenberg, Jeffrey ; Anthony, Navin ; Dale, William

In The Lancet 20-26 November 2021 398(10314):1894-1904

Fuller, Sophia; Alexeeff, Stacey; Caan, Bette; Goncalves, Marcus D; Dunne, Richard F; Janowitz, Tobias; Jamal-Hanjani, Mariam; Sundaresan, Tilak K; Feliciano, Elizabeth M Cespedes

JNCI: Journal of the National Cancer Institute. Aug2025, Vol. 117 Issue 8, p1729-1732. 4p.

Elahjji R; Weill Cornell Medicine, New York, New York, USA.; Blow T; Weill Cornell Medicine, New York, New York, USA.; Grover R; Weill Cornell Medicine, New York, New York, USA.; Hurd MA; Weill Cornell Medicine, New York, New York, USA.; Dunne RF; University of Rochester Medical Center, Rochester, New York, USA.; Caan BJ; Kaiser Permanente, Oakland, California, USA.; Cespedes Feliciano EM; Kaiser Permanente, Oakland, California, USA.; Plodkowski AJ; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Flory JH; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Goncalves MD; Weill Cornell Medicine, New York, New York, USA.

Publisher: John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders Country of Publication: Germany NLM ID: 101552883 Publication Model: Print Cited Medium: Internet ISSN: 2190-6009 (Electronic) Linking ISSN: 21905991 NLM ISO Abbreviation: J Cachexia Sarcopenia Muscle Subsets: MEDLINE

Papadopoulos E; School of Kinesiology, Louisiana State University, Baton Rouge, LA, USA. epap@lsu.edu.; Irving BA; School of Kinesiology, Louisiana State University, Baton Rouge, LA, USA.; Brown JC; Exercise and Cancer Biology Research Program, Advent Health, Orlando, FL, USA.; Heymsfield SB; Metabolism and Body Composition, Pennington Biomedical Research Center, Baton Rouge, LA, USA.; Sattar S; College of Nursing, University of Saskatchewan, Saskatoon, SK, Canada.; Alibhai SMH; Department of Supportive Care, Princess Margaret Cancer Center, Toronto, ON, Canada.; Department of Medicine, University Health Network and University of Toronto, Toronto, ON, Canada.; Williams GR; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.; Dunne RF; Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, USA.

Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9102074 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1969 (Electronic) Linking ISSN: 1170229X NLM ISO Abbreviation: Drugs Aging Subsets: MEDLINE

Chen IY; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.; Dunne RF; Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.; Liao X; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA. xiaoyan_liao@urmc.rochester.edu.

Publisher: Springer International Country of Publication: Germany NLM ID: 9423843 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2307 (Electronic) Linking ISSN: 09456317 NLM ISO Abbreviation: Virchows Arch Subsets: MEDLINE

Jensen-Battaglia M; James P. Wilmot Cancer Institute, Rochester, New York, USA. marielle_jensenbattaglia@urmc.rochester.edu.; Department of Public Health Sciences, University of Rochester Medical Center, Rochester, USA. marielle_jensenbattaglia@urmc.rochester.edu.; Lin PJ; James P. Wilmot Cancer Institute, Rochester, New York, USA.; Department of Surgery, University of Rochester Medical Center, New York, USA.; Sanapala C; James P. Wilmot Cancer Institute, Rochester, New York, USA.; Watson EE; Princeton University, New Jersey, United States.; Mendler JH; James P. Wilmot Cancer Institute, Rochester, New York, USA.; Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, James P. Wilmot Cancer Institute, 601 Elmwood Avenue, Box 704, Rochester, New York, 14642, USA.; Liesveld J; James P. Wilmot Cancer Institute, Rochester, New York, USA.; Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, James P. Wilmot Cancer Institute, 601 Elmwood Avenue, Box 704, Rochester, New York, 14642, USA.; Wang Y; James P. Wilmot Cancer Institute, Rochester, New York, USA.; Department of Public Health Sciences, University of Rochester Medical Center, Rochester, USA.; Hayward E; James P. Wilmot Cancer Institute, Rochester, New York, USA.; Emory University, Atlanta, USA.; LoCastro M; James P. Wilmot Cancer Institute, Rochester, New York, USA.; Mortaz S; James P. Wilmot Cancer Institute, Rochester, New York, USA.; Dunne RF; James P. Wilmot Cancer Institute, Rochester, New York, USA.; Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, James P. Wilmot Cancer Institute, 601 Elmwood Avenue, Box 704, Rochester, New York, 14642, USA.; Mustian K; James P. Wilmot Cancer Institute, Rochester, New York, USA.; Department of Surgery, University of Rochester Medical Center, New York, USA.; Loh KP; James P. Wilmot Cancer Institute, Rochester, New York, USA. kahpoh_loh@urmc.rochester.edu.; Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, James P. Wilmot Cancer Institute, 601 Elmwood Avenue, Box 704, Rochester, New York, 14642, USA. kahpoh_loh@urmc.rochester.edu.

Publisher: BioMed Central Country of Publication: England NLM ID: 100968548 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2318 (Electronic) Linking ISSN: 14712318 NLM ISO Abbreviation: BMC Geriatr Subsets: MEDLINE

Byrne MM; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.; Chávez-Villa M; Division of Transplant Surgery, Mayo Clinic, Phoenix, Arizona, USA.; Ruffolo LI; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.; Loria A; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.; Endo Y; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Niewiemski A; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Jimenez-Soto C; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Melaragno JI; Department of Pharmacy, University of Rochester Medical Center, Rochester, New York, USA.; Ramaraju GA; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Farooq PD; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Dunne RF; Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA.; Pineda-Solis K; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Nair A; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Orloff M; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Tomiyama K; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Hernandez-Alejandro R; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA. Electronic address: roberto_hernandez@urmc.rochester.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 100968638 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-6143 (Electronic) Linking ISSN: 16006135 NLM ISO Abbreviation: Am J Transplant Subsets: MEDLINE; In Process

Byrne MM; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.; Dunne RF; Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA.; Hernandez-Alejandro R; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Tomiyama K; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA. Electronic address: koji_tomiyama@urmc.rochester.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 100968638 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-6143 (Electronic) Linking ISSN: 16006135 NLM ISO Abbreviation: Am J Transplant Subsets: MEDLINE; In Process

Singhal S; Division of Hematology/Oncology, Department of Medicine, University of California Davis, California, USA.; Wang Y; Department of Public Health Sciences, University of Rochester Medical Center, New York, USA.; Dunne RF; Division of Hematology and Oncology, James P. Wilmot Cancer Institute, University of Rochester Medical Center, New York, USA.; Kehoe L; Division of Supportive Care in Cancer, Department of Surgery, James P. Wilmot Cancer Institute, University of Rochester Medical Center, New York, USA.; Sohn MB; Department of Biostatistics and Computational Biology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.; Jensen-Battaglia M; Department of Public Health Sciences, University of Rochester Medical Center, New York, USA.; Canin B; Stakeholders for Care in Oncology and Research for Our Elders (SCOREBoard) Advisory Committee, California, USA.; Tylock R; Division of Hematology and Oncology, James P. Wilmot Cancer Institute, University of Rochester Medical Center, New York, USA.; Mohamed M; Department of Public Health Sciences, University of Rochester Medical Center, New York, USA.; Khatri J; Delaware/Christiana Care NCI Community Oncology Research Program (NCORP), Delaware, USA.; Bearden J 3rd; Southeast Clinical Oncology Research Consortium NCORP, Spartanburg, South Carolina, USA.; Philip T; Northwell Health Cancer Institute, New York, USA.; Mohile S; Division of Hematology and Oncology, James P. Wilmot Cancer Institute, University of Rochester Medical Center, New York, USA.; Loh KP; Division of Hematology and Oncology, James P. Wilmot Cancer Institute, University of Rochester Medical Center, New York, USA.

Publisher: Blackwell Science Country of Publication: United States NLM ID: 7503062 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-5415 (Electronic) Linking ISSN: 00028614 NLM ISO Abbreviation: J Am Geriatr Soc Subsets: MEDLINE

Dunne RF; Department of Medicine and Wilmot Cancer Institute, Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, New York, USA.; Crawford J; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.; Smoyer KE; Envision Pharma Group, Fairfield, Connecticut, USA.; McRae TD; Department of Internal Medicine, Pfizer Research and Development, Pfizer Inc, New York, New York, USA.; Rossulek MI; Internal Medicine Research Unit, Pfizer Research and Development, Pfizer Inc, Cambridge, Massachusetts, USA.; Revkin JH; Internal Medicine Research Unit, Pfizer Research and Development, Pfizer Inc, Cambridge, Massachusetts, USA.; Tarasenko LC; Global Medical Affairs, Pfizer Inc, New York, New York, USA.; Bonomi PD; Department of Internal Medicine, Division of Hematology, Oncology and Cell Therapy, Rush University Medical Center, Chicago, Illinois, USA.

Publisher: John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders Country of Publication: Germany NLM ID: 101552883 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-6009 (Electronic) Linking ISSN: 21905991 NLM ISO Abbreviation: J Cachexia Sarcopenia Muscle Subsets: MEDLINE

Kleckner IR; University of Maryland School of Nursing, Baltimore, MD, 21201, USA. ian.kleckner@umaryland.edu.; Manuweera T; University of Maryland School of Nursing, Baltimore, MD, 21201, USA.; Lin PJ; University of Rochester Medical Center, 265 Crittenden Blvd, Box CU 420658, Rochester, NY, 14642, USA.; Chung KH; University of Maryland School of Nursing, Baltimore, MD, 21201, USA.; Cornell University, Ithaca, NY, 14853, USA.; Kleckner AS; University of Maryland School of Nursing, Baltimore, MD, 21201, USA.; Gewandter JS; University of Rochester Medical Center, 265 Crittenden Blvd, Box CU 420658, Rochester, NY, 14642, USA.; Culakova E; University of Rochester Medical Center, 265 Crittenden Blvd, Box CU 420658, Rochester, NY, 14642, USA.; Tivarus ME; University of Rochester Medical Center, 265 Crittenden Blvd, Box CU 420658, Rochester, NY, 14642, USA.; Dunne RF; University of Rochester Medical Center, 265 Crittenden Blvd, Box CU 420658, Rochester, NY, 14642, USA.; Loh KP; University of Rochester Medical Center, 265 Crittenden Blvd, Box CU 420658, Rochester, NY, 14642, USA.; Mohile NA; University of Rochester Medical Center, 265 Crittenden Blvd, Box CU 420658, Rochester, NY, 14642, USA.; Kesler SR; University of Texas at Austin, Austin, TX, 78712, USA.; Mustian KM; University of Rochester Medical Center, 265 Crittenden Blvd, Box CU 420658, Rochester, NY, 14642, USA.

Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

Bonomi PD; Department of Internal Medicine, Division of Hematology, Oncology and Cell Therapy, Rush University Medical Center, Chicago, IL, USA.; Crawford J; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.; Dunne RF; Department of Medicine and Wilmot Cancer Institute, Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, NY, USA.; Roeland EJ; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.; Smoyer KE; Curo, Envision Pharma Group, Philadelphia, PA, USA.; Siddiqui MK; EBM Health Consultants, New Delhi, Delhi, India.; McRae TD; Internal Medicine Business Unit, Global Product Development, Pfizer Inc, New York, NY, USA.; Rossulek MI; Internal Medicine Research Unit, Worldwide Research, Development and Medical, Pfizer Inc, Cambridge, MA, USA.; Revkin JH; Internal Medicine Research Unit, Clinical Development, Pfizer Inc, Cambridge, MA, USA.; Tarasenko LC; Global Medical Affairs, Pfizer Inc, New York, NY, USA.

Publisher: John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders Country of Publication: Germany NLM ID: 101552883 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-6009 (Electronic) Linking ISSN: 21905991 NLM ISO Abbreviation: J Cachexia Sarcopenia Muscle Subsets: MEDLINE

Goncalves MD; NYU Langone Health, New York, NY.; Dunne RF; University of Rochester Medical Center, Rochester, NY.; Moore AC; Lungevity Foundation, Chicago, IL.; Phillips W; Morrison Healthcare, Atlanta, GA.; Heymsfield SB; Pennington Biomedical Research Center, Baton Rouge, LA.; Brown JC; Pennington Biomedical Research Center, Baton Rouge, LA.; Talbert EE; University of Iowa, Iowa City, IA.; Janowitz T; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

Williams, Grant R; Dunne, Richard F; Giri, Smith; Shachar, Shlomit S; Caan, Bette J

Journal of Clinical Oncology. 7/1/2021, Vol. 39 Issue 19, p2068-2078. 11p.

Byrne MM; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.; Chávez-Villa M; Division of Transplant Surgery, Mayo Clinic, Phoenix, Arizona, USA.; Ruffolo LI; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.; Loria A; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.; Endo Y; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Niewiemski A; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Jimenez-Soto C; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Melaragno JI; Department of Pharmacy, University of Rochester Medical Center, Rochester, New York, USA.; Ramaraju GA; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Farooq PD; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Dunne RF; Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA.; Pineda-Solis K; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Nair A; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Orloff M; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Tomiyama K; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Hernandez-Alejandro R; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA. Electronic address: roberto_hernandez@urmc.rochester.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 100968638 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-6143 (Electronic) Linking ISSN: 16006135 NLM ISO Abbreviation: Am J Transplant Subsets: MEDLINE

Byrne MM; Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA. Electronic address: matthew_byrne@urmc.rochester.edu.; Dunne RF; Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA.; Melaragno JI; Department of Pharmacy, University of Rochester Medical Center, Rochester, New York, USA.; Chávez-Villa M; Division of Transplant Surgery, Department of Surgery, Mayo Clinic, Phoenix, Arizona, USA.; Hezel A; Department of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA.; Liao X; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, USA.; Ertreo M; Department of Imaging Sciences, University of Rochester Medical Center, Rochester, New York, USA.; Al-Judaibi B; Liver and Small Bowel Health Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.; Orloff M; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Hernandez-Alejandro R; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.; Tomiyama K; Transplant Institute, University of Rochester Medical Center, Rochester, New York, USA.

Publisher: Elsevier Country of Publication: United States NLM ID: 100968638 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-6143 (Electronic) Linking ISSN: 16006135 NLM ISO Abbreviation: Am J Transplant Subsets: MEDLINE

Groarke JD; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Crawford J; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Collins SM; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Lubaczewski S; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Roeland EJ; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Naito T; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Hendifar AE; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Fallon M; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Takayama K; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Asmis T; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Dunne RF; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Karahanoglu I; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Northcott CA; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Harrington MA; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Rossulek M; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Qiu R; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).; Saxena AR; From the Internal Medicine Research Unit (J.D.G., I.K., M.A.H., A.R.S.) and Clinical Pharmacology (R.Q.), Pfizer, Cambridge, MA; Duke Cancer Institute, Duke University Medical Center, Durham, NC (J.C.); Global Biometrics and Data Management, Pfizer R&D UK, Sandwich (S.M.C.), and Edinburgh Cancer Research Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh (M.F.) - both in the United Kingdom; Translational Clinical Sciences, Pfizer, Collegeville, PA (S.L.); Knight Cancer Institute, Oregon Health and Science University, Portland (E.J.R.); the Cancer Supportive Care Center, Shizuoka Cancer Center, Shizuoka (T.N.), and the Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine, Kyoto (K.T.) - both in Japan; Cedars-Sinai Medical Center, Los Angeles (A.E.H.); the Ottawa Hospital Cancer Centre, Ottawa (T.A.); Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY (R.F.D.); Translational Clinical Sciences, Pfizer, Groton, CT (C.A.N.); and the Internal Medicine Research Unit, Pfizer, Tampa, FL (M.R.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Arora, Sukeshi Patel; Liposits, Gabor; Caird, Susan; Dunne, Richard F; Moffat, Gordon Taylor; Okonji, David; Rodriquenz, Maria Grazia; Dua, Divyanshu; Dotan, Efrat

Journal of Geriatric Oncology. 11:557-565

Singhal S; Division of Hematology/Oncology, Department of Medicine, University of California Davis, Sacramento, California, USA.; Wang Y; Department of Public Health Sciences, University of Rochester Medical Center, Rochester, New York, USA.; Qin Z; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York, USA.; Peterson DR; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York, USA.; Dunne RF; Division of Hematology and Oncology, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA.; Culakova E; Department of Surgery, Supportive Care in Cancer Unit, University of Rochester, Rochester, New York, USA.; Hopkins JO; Novant Health Cancer Institute/Southeast Clinical Oncology Research Consortium, Winston-Salem, North Carolina, USA.; Melnyk N; Delaware/Christiana Care NCI Community Oncology Research Program (NCORP), Newark, Delaware, USA.; Onitilo A; Wisconsin NCORP, Marshfield, Wisconsin, USA.; Targia V; Stakeholders for the Care and Research of Oncology Elders (SCOREBoard) Advisory Committee, Duarte, USA.; Mohile S; Division of Hematology and Oncology, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA.; Loh KP; Division of Hematology and Oncology, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA.

Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

Morales-Oyarvide, Vicente; Rubinson, Douglas A; Dunne, Richard F; Kozak, Margaret M; Bui, Justin L; Yuan, Chen; Qian, Zhi Rong; Babic, Ana; Da Silva, Annacarolina; Nowak, Jonathan A; Khalaf, Natalia; Brais, Lauren K; Welch, Marisa W; Zellers, Caitlin L; Ng, Kimmie; Chang, Daniel T; Miksad, Rebecca A; Bullock, Andrea J; Tseng, Jennifer F; Swanson, Richard S

British Journal of Cancer. 12/5/2017, Vol. 117 Issue 12, p1874-1882. 9p. 5 Charts, 1 Graph.